CLASS II ONGOING Device recall · Reported 16 Apr 2025 · FDA Enforcement Report

FilmArra Pneumonia Panel plus (Pneumoplus) recalled

BioFire Diagnostics is recalling FilmArra Pneumonia Panel plus (Pneumoplus). The recall was initiated on 27 Feb 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 00815381020314/Lot# 0979424
Quantity recalled29 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1518-2025
FDA event ID
96346
Recalling firm
BioFire Diagnostics, Salt Lake City, UT
Classification
Class II
Status
Ongoing
Recall initiated
27 Feb 2025
FDA classified
4 Apr 2025
Reported
16 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

27 Feb 2025Recall initiated by company
4 Apr 2025Classified by FDA+36 days
16 Apr 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Increased risk of control failures and false negative test results with multiplexed nucleic acid test.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374

Where it was distributed

OUS International Distribution to countries of: France, Italia, Spain, Switzerland, Israel

Questions about this recall

Why was it recalled?

Increased risk of control failures and false negative test results with multiplexed nucleic acid test.

Which lots are affected?

UDI: 00815381020314/Lot# 0979424

Where was it sold?

OUS International Distribution to countries of: France, Italia, Spain, Switzerland, Israel

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from BioFire Diagnostics

All 44

Other Other Medical Devices recalls

All 13,884